Skip to Content

Join the 'Spiriva HandiHaler' group to help and get support from people like you.

Spiriva HandiHaler News

Long-Acting Inhaler May Help in Early Stage COPD, Too

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – The inhaler medication Spiriva (tiotropium bromide) may help slow the progression of COPD if given in the early stages of the disease, a new study suggests. Researchers found that the drug helped patients preserve more lung function over two years. It also cut down on symptom flare-ups and boosted patients' quality of life, on average. All of the study patients were in ...

Obesity May Raise Girls' Risk of Asthma, Allergies

Posted 6 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – Obese girls may face a significantly higher risk for developing allergies, a new study suggests. But the researchers found the opposite was true for obese boys: They may actually face a slightly diminished risk for asthma, food allergies and eczema when compared to normal-weight boys. "We found a direct increase in the number of atopic [allergic] diseases associated with ...

FDA Expands Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children

Posted 27 Feb 2017 by Drugs.com

RIDGEFIELD, Conn., February 16, 2017 - Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. Spiriva Respimat is not a treatment for sudden asthma symptoms. The FDA approved the Supplemental New Drug Application (sNDA) under a ...

Mice May Be Key to Kids' Asthma Attacks at School

Posted 2 Dec 2016 by Drugs.com

FRIDAY, Dec. 2, 2016 – Research investigating schoolchildren's asthma attacks has pointed to a tiny foe: mice. Allergens from the rodents can infiltrate the air, the study found, and may be a major cause of asthma attacks in the school environment. It's known that many different allergy triggers – from dust mites to mold to pet dander – can fuel children's asthma symptoms. But most research ...

COPD Deaths Down for Most Americans: CDC

Posted 8 Sep 2016 by Drugs.com

THURSDAY, Sept. 8, 2016 – Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows. Between 2000 and 2014, there was a 12 percent overall drop in deaths from the progressive lung disease, according to the U.S. Centers for Disease Control and Prevention. Report co-author Hanyu Ni said the figures aren't ...

Secondhand Smoke May Double Risk of Hospitalization for Kids With Asthma

Posted 24 Sep 2015 by Drugs.com

THURSDAY, Sept. 24, 2015 – Exposure to secondhand smoke puts children with asthma at nearly double the risk of winding up in the hospital, a new analysis reveals. For these kids, secondhand smoke can worsen symptoms and make their condition more difficult to control. So parents need to be aware of these additional risks, the researchers warned. "Previous studies have linked secondhand smoke ...

Asthma Treatments Fail Older Patients More Often: Study

Posted 12 Jun 2015 by Drugs.com

FRIDAY, June 12, 2015 – Asthma treatments, especially inhaled corticosteroids, are less likely to work for older patients, a new study suggests. Researchers looked at 1,200 patients with mild-to-moderate asthma, and found that treatment failure occurred in about 17 percent of those aged 30 and older, compared with about 10 percent of those younger than 30. Lower lung function and having asthma ...

FDA Approves Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray for COPD

Posted 26 May 2015 by Drugs.com

RIDGEFIELD, Conn., May 26, 2015 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray. It has been approved as a long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis a ...

FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD

Posted 25 Sep 2014 by Drugs.com

Ridgefield, Conn., September 25, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat (tiotropium bromide) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema and to reduce ...

Certain COPD Meds Might Raise Heart Risks, Study Says

Posted 20 May 2013 by Drugs.com

MONDAY, May 20 – Long-acting inhaled medications used by millions of people with chronic obstructive pulmonary disease (COPD) may raise the risk of cardiovascular complications among older patients, a new large Canadian study reveals. The finding centers around patients over age 65 who are prescribed long-acting bronchodilators – either anticholinergics (such as Spiriva) or beta-agonists (such ...

Seniors Undertreated for Asthma, and Many Skip Inhalers: Study

Posted 1 May 2012 by Drugs.com

TUESDAY, May 1 – Asthma often is misdiagnosed and undertreated in older people, with only 53 percent of those with asthma using prescribed inhalers, a small new study suggests. The study included 77 people, including people both with and without asthma, who were over age 60. Of those with asthma, 89 percent also had allergies to mold, animals or dust mites. The asthma patients were more likely ...

Rapid Asthma Treatment in ER May Prevent Admission

Posted 6 Apr 2012 by Drugs.com

FRIDAY, April 6 – Rapid treatment with asthma medications seems to help reduce hospitalizations among children with asthma, a new study finds. Canadian researchers analyzed data from 406 children and found that those with moderate or severe asthma attacks who received systemic corticosteroids within 75 minutes of arriving at a hospital emergency department were 16 percent less likely to be ...

Asthma Meds Likely Safe During Pregnancy: Study

Posted 20 Jan 2012 by Drugs.com

FRIDAY, Jan. 20 – A new study found no statistically significant link between asthma medication use during pregnancy and common birth defects. However, the study did find a positive association between some rare birth defects and mothers with asthma, and potentially with their medication use. But, the researchers couldn't tease out whether the problem was a loss of oxygen from less than ...

New Guidelines for Spotting, Treating COPD Released

Posted 1 Aug 2011 by Drugs.com

MONDAY, Aug. 1 – Four of the world's leading pulmonary associations have issued new guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease, one of the world's leading killers. While the recommendations are based on more recent studies of the disorder, they differ little from previous guidelines and are meant largely to emphasize how critical it is to manage the ...

Researchers Question Safety of Mist Inhalers for Delivering Common Drug for Chronic Lung Disease

Posted 15 Jun 2011 by Drugs.com

BALTIMORE, June 14, 2011 - People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests. The findings, published by BMJ, the British medical journal, raise concerns not only about the mist inhaler — a device that delivers the soluble f ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Asthma - Maintenance

Related Drug Support Groups

Spiriva, Spiriva HandiHaler, Spiriva Respimat

Spiriva HandiHaler Patient Information at Drugs.com